Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
37 studies found for:    " October 07, 2009":" November 06, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Motivational Enhancement System for Adherence
Condition: HIV
Interventions: Behavioral: Motivational Enhancement System for Adherence (MESA);   Behavioral: Motivational Enhancement System for Health (MESH)
22 No longer available A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Open Label Treatment Access: Maraviroc
23 Completed
Has Results
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
Conditions: HIV Infections;   H1N1 Influenza Virus
Intervention: Biological: Influenza A (H1N1) monovalent vaccine
24 Completed
Has Results
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Drug: maraviroc;   Drug: darunavir;   Drug: ritonavir
25 Completed
Has Results
A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Drug: MK0518 (Raltegravir);   Drug: famotidine;   Drug: omeprazole
26 Completed Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1
Condition: HIV-1 Infections
Intervention: Drug: BMS-663068 with or without ritonavir
27 Completed Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV
Conditions: HIV Infections;   H1N1 Influenza
Intervention: Biological: Arepanrix
28 Unknown  CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients
Condition: HIV-1 Infections
Interventions: Drug: IL-2 (~1.2M IU/m2);   Biological: T Cell infusion 5-10 x E9 T cells
29 Completed ADHEPTA Study: Adherence Questionnaire in Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV Infection
Intervention: Other: Adherence questionnaire
30 Completed Managerial Database II
Condition: HIV
Intervention: Other: Observation
31 Completed Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Atazanavir/Ritonavir;   Drug: Tenofovir/Emtricitabine
32 Completed
Has Results
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
Conditions: HIV Infection;   Hepatitis C Infection
Interventions: Drug: Nitazoxanide (NTZ);   Drug: Pegylated interferon alfa-2a (PEG);   Drug: Ribavirin (RBV)
33 Completed Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4
Conditions: Liver Cirrhosis;   Hepatitis C Virus;   HIV Infection
Intervention: Drug: Pegylated interferon alfa-2a and Ribavirin
34 Active, not recruiting Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)
Conditions: Fetal Alcohol Syndrome;   HIV;   Nutrition Disorders
Intervention: Behavioral: Philani Intervention Program
35 Completed
Has Results
H1N1 Vaccine at Two Dose Levels in HIV Positive Adults
Condition: Influenza
Intervention: Biological: Inactivated Influenza H1N1 vaccine
36 Completed Support To Reunite Involve and Value Each Other
Conditions: Family Relations;   Runaway Behavior;   Risky Sexual Behavior;   Substance Use
Intervention: Behavioral: STRIVE family intervention
37 Completed Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Methemoglobinemia;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Nonmalignant Neoplasm
Interventions: Drug: chemotherapy;   Drug: dapsone;   Other: medical chart review;   Procedure: assessment of therapy complications

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Study has passed its completion date and status has not been verified in more than two years.